ABSTRACT Twelve patients fulfilling strict criteria for chronic obstructive bronchitis recorded serial peak expiratory flow rates (PEFR) five times daily for a two-week period. Despite a 9-2 % improvement in forced expiratory volume in one second (FEV1) with ipratropium bromide, and an 113 % improvement with ipratropium bromide plus salbutamol, the inherent diurnal variation in PEFR while on no medication was greater than the improvement caused by either bronchodilator. In the group as a whole, the difference between the highest and the lowest daily PEFR over the two weeks was 24 % of the mean daily value. Using cosinor analysis, 10 of the 12 patients showed a significant rhythm in PEFR with a computed mean amplitude between highest and lowest readings of 8-6 % of the mean daily value. This is no greater than that found in normal subjects, but is considerably less than the variation in PEFR in patients with bronchial asthma.
Patients with chronic obstructive bronchitis caused by cigarette smoking often complain that their symptoms, particularly of breathlessness, are worse on waking than they are at other times of the day, although this clinical impression has never been analysed formally. However, it is known that nonsmoking asthmatics frequently suffer exacerbations in the early hours of the morning.1 2 The diurnal variation in airway resistance which may underlie these asthmatic exacerbations has been studied extensively both in asthmatic patients,3-10 and in normal subjects. 45 9-13 It has been shown that both groups exhibit a circadian rhythm in phase with the pattern of sleep, but not dependent on sleep itself,14 and that airway resistance usually reaches a peak between 0400-0600 hours. The amplitude of the variation in peak expiratory flow rate in normals is about 8 % of the mean daily value,9 whereas in asthmatics the amplitude is often much greater, and this is exaggerated during the acute attack. 2 Similar patterns have been observed in two reports5 8 and after ipratropium bromide plus salbutamol (FEVlS-FEVlB/FEViB%). In the group as a whole there was a 92% (SD+6-4% p<0001) improvement with ipratropium bromide (FEV,B/FEVlA), and a 11-3% (SD±8-4% p<0 001) improvement after the two agents (FEVlB/FEVlS). However, the addition of salbutamol to the ipratropium bromide did not make a significant difference (mean improvement + 2-1 % SD ± 7 0 % p = 0 5). The highest and lowest PEFR were recorded for each day, and the mean readings over the two-week period are shown for each patient in table 3 . The mean absolute difference in PEFR for each patient and the variation in PEFR expressed as a percentage of the mean reading are also shown. In the group as a whole the mean difference between the highest and the lowest PEFR, expressed as a percentage of the mean, was 24 (SD ± 12) % over the two weeks, and the mean absolute variation was 44 (SD ± 15) litres/ min.
In order to determine whether there was a significant diurnal rhythm in PEFR, the data were analysed for each patient by regressing all the peak flow readings on cos(2t/247r) and sin(27rt/24). This regression model, usually called cosinor analysis, enables the amplitude and phase of the best fit sine curve with a period of 24 hours to be estimated. This method has been described in detail elsewhere.9 10 19 Dawkinis, Muers 
Discussion
We have studied the diurnal variation in airflow resistance in a group of patients with airflow obstruction caused by cigarette smoking and without evidence of atopy, late onset "asthma", or bronchial hyperreactivity. As is typical of bronchitic patients, most (10 out of 12) improved significantly (p < 0-001) with ipratropium bromide, and although there was a tendency for further improvement with the addition of salbutamol, this was not significant. Two patients (6 and 12) actually deteriorated with salbutamol. This phenomenon is unexplained but it has been noted previously (DJ Lane, personal communication, 1979 ). However, in 11 patients the mean daily variation in PEFR while on no medication was greater than the improvement shown with either ipratropium bromide, or ipratropium bromide plus salbutamol. This observation has important implications when assessing the efficacy of drugs used in the treatment of airflow obstruction. Patients may well be labelled as having a "reversible" component to their airflow obstruction, when in reality the improvement noted after a bronchodilator is significantly less than their own inherent diurnal variation.
Using cosinor analysis, 10 patients in the group showed a significant daily rhythm in PEFR at the 5 % level. Hetzel and colleagues9 10 13 have shown in normal subjects a computed variation in PEFR of 8-3 (SD ± 5 2) % of the mean daily value. They suggest that a variation of over 20 % might be a useful screening test for bronchial asthma. Diurnal variation in PEFR is not age-dependent, and the duration of symptoms in the bronchitic and asthmatic groups was similar (mean 22 years and 18 years respectively). The bronchitics showed a variation of (SD ± 5 7) %, virtually identical to that found in normal subjects, suggesting that this may be an additional method of distinguishing between patients with airflow obstruction caused by cigarette smoking and airflow obstruction caused by intrinsic bronchial hyperreactivity. One of the advantages of using cosinor analysis is that, assuming enough PEFR readings are taken within a 24-hour cycle, the peak and trough values may be computed, even if an actual reading was not taken at that particular time. The computed high PEFR for the bronchitic group occurred at 1620 hours (again similar to normals of between 1500 and 1700 hours), with a trough 12 hours later at 0420 (SD ±3) hours. This suggests that the diurnal variation in airways obstruction may well be the reason why patients with this disease often complain of being at their worst in the early morning.
The mechanism or mechanisms which underlie the circadian rhythm in airway calibre remain obscure. It 
